Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) General Information
Description
A monoclonal antibody to treat virus infections of kidney transplant patients in San Diego, California.
Contact Information
Corporate Office
- 12730 High Bluff Drive
- Suite 160
- San Diego, CA 92130
- United States
Corporate Office
- 12730 High Bluff Drive
- Suite 160
- San Diego, CA 92130
- United States
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) FAQs
-
Where is Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) headquartered?
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) is headquartered in San Diego, CA.
-
What industry is Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) in?
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868)’s primary industry is Drug Discovery.
-
Is Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) a private or public company?
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) is a Private company.
-
What is the current valuation of Amplyx Pharmaceuticals (Monoclonal Antibody MAU868)?
The current valuation of Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) is .
-
What is Amplyx Pharmaceuticals (Monoclonal Antibody MAU868)’s current revenue?
The current revenue for Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) is .
-
Who are Amplyx Pharmaceuticals (Monoclonal Antibody MAU868)’s investors?
Amplyx Pharmaceuticals has invested in Amplyx Pharmaceuticals (Monoclonal Antibody MAU868).
-
When was Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) acquired?
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) was acquired on 17-Dec-2021.
-
Who acquired Amplyx Pharmaceuticals (Monoclonal Antibody MAU868)?
Amplyx Pharmaceuticals (Monoclonal Antibody MAU868) was acquired by Vera Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process